What is the other name for Ruxolitinib phosphate? An Overview of Jakafi, Opzelura, and More
•
2 min read
First approved by the FDA in 2011, Ruxolitinib phosphate is a medication that has since gained several other names and applications. This targeted therapy is a potent inhibitor of Janus kinases (JAKs), a crucial pathway involved in many inflammatory and proliferative conditions. Depending on its formulation and the condition being treated, it is marketed under different brand names, so understanding **what is the other name for Ruxolitinib phosphate?** is essential for patients and healthcare providers.
